ZA201601656B - Inhalable pharmaceutical composition - Google Patents
Inhalable pharmaceutical compositionInfo
- Publication number
- ZA201601656B ZA201601656B ZA2016/01656A ZA201601656A ZA201601656B ZA 201601656 B ZA201601656 B ZA 201601656B ZA 2016/01656 A ZA2016/01656 A ZA 2016/01656A ZA 201601656 A ZA201601656 A ZA 201601656A ZA 201601656 B ZA201601656 B ZA 201601656B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- inhalable pharmaceutical
- inhalable
- composition
- pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN770MU2015 | 2015-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201601656B true ZA201601656B (en) | 2017-06-28 |
Family
ID=55543006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2016/01656A ZA201601656B (en) | 2015-03-10 | 2016-03-10 | Inhalable pharmaceutical composition |
Country Status (2)
| Country | Link |
|---|---|
| WO (1) | WO2016142708A2 (en) |
| ZA (1) | ZA201601656B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109077998B (en) * | 2017-06-13 | 2023-02-03 | 恩康药业科技(广州)有限公司 | Salmeterol lipid complex and preparation method thereof |
| CN109758436A (en) * | 2017-11-09 | 2019-05-17 | 北京盈科瑞创新药物研究有限公司 | A kind of Neulized inhalation pirfenidone freeze-dried lipidosome preparation and preparation method thereof |
| CN109758437A (en) * | 2017-11-09 | 2019-05-17 | 北京盈科瑞创新药物研究有限公司 | A kind of Neulized inhalation Nintedanib freeze-dried lipidosome preparation and preparation method thereof |
| CN108175764B (en) * | 2017-12-19 | 2020-02-21 | 亿腾医药(苏州)有限公司 | Anhydrous beclomethasone dipropionate sterile powder and preparation method of inhalation suspension |
| WO2019202400A1 (en) * | 2018-04-17 | 2019-10-24 | Universite De Caen Normandie | Bambuterol for the treatment of alzheimer's disease |
| CN110742875B (en) * | 2018-07-05 | 2022-09-30 | 北京盈科瑞创新药物研究有限公司 | Pirfenidone solution preparation for inhalation and preparation method and application thereof |
| CN112823009A (en) * | 2019-08-28 | 2021-05-18 | 上海谷森医药有限公司 | Fluticasone furoate liposome preparation and preparation method thereof |
| WO2021150471A1 (en) * | 2020-01-20 | 2021-07-29 | Huang Cai Gu | Liposome formulation of vilanterol trifenatate |
| CN111729087A (en) * | 2020-07-24 | 2020-10-02 | 成都大学 | Lipid modification of a selective β2 receptor agonist and preparation method and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5258499A (en) * | 1988-05-16 | 1993-11-02 | Vestar, Inc. | Liposome targeting using receptor specific ligands |
| US20020052310A1 (en) * | 1997-09-15 | 2002-05-02 | Massachusetts Institute Of Technology The Penn State Research Foundation | Particles for inhalation having sustained release properties |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| WO2002083840A2 (en) * | 2001-04-03 | 2002-10-24 | Arizeke Pharmaceuticals, Inc. | Compositions and methods for transepithelial transport of membrane-bounded vesicles and virions |
| US7754242B2 (en) * | 2002-03-20 | 2010-07-13 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| AU2003230689B2 (en) * | 2002-03-20 | 2006-06-29 | Alkermes, Inc. | Inhalable sustained therapeutic formulations |
| CA2898700C (en) | 2013-03-14 | 2022-07-19 | Novartis Ag | Deamorphization of spray-dried formulations via spray-blending |
| US9452139B2 (en) * | 2013-03-14 | 2016-09-27 | Novartis Ag | Respirable agglomerates of porous carrier particles and micronized drug |
-
2016
- 2016-03-09 WO PCT/GB2016/050645 patent/WO2016142708A2/en not_active Ceased
- 2016-03-10 ZA ZA2016/01656A patent/ZA201601656B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016142708A3 (en) | 2016-12-29 |
| WO2016142708A2 (en) | 2016-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL265260B (en) | Pharmaceutical composition | |
| IL265360A (en) | Pharmaceutical composition | |
| IL262654A (en) | Pharmaceutical composition | |
| GB201409471D0 (en) | Pharmaceutical composition | |
| ZA201601656B (en) | Inhalable pharmaceutical composition | |
| GB201409488D0 (en) | Pharmaceutical composition | |
| IL265349A (en) | Pharmaceutical composition | |
| GB201409485D0 (en) | Pharmaceutical composition | |
| HUE046729T2 (en) | Pharmaceutical composition containing mirabegron | |
| GB201521462D0 (en) | Pharmaceutical composition | |
| GB201506526D0 (en) | Medicinal composition | |
| IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
| PL3313370T3 (en) | Ophthalmologic pharmaceutical composition | |
| ZA201508726B (en) | Pharmaceutical composition | |
| ZA201502073B (en) | Pharmaceutical composition | |
| IL255510A (en) | Pharmaceutical compositions | |
| PL3454838T3 (en) | Pharmaceutical composition | |
| GB201615917D0 (en) | Pharmaceutical composition | |
| GB201515310D0 (en) | Pharmaceutical composition | |
| GB201615914D0 (en) | Pharmaceutical composition | |
| GB201520862D0 (en) | Pharmaceutical composition | |
| LT3089740T (en) | Pharmaceutical composition | |
| GB201615910D0 (en) | Pharmaceutical composition | |
| SG10201504332VA (en) | Pharmaceutical Composition | |
| ZA201500995B (en) | Low dose pharmaceutical composition |